BioVie Inc. Notes Payable, Current
BioVie Inc. (BIVI) had Notes Payable, Current of $3.32 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-06
- 2024-09-30: Notes Payable, Current $3.32M.
- 2024-06-30: Notes Payable, Current $5.70M.
- 2024-03-31: Notes Payable, Current $7.99M.
- 2023-12-31: Notes Payable, Current $10.20M.
| Period end | Notes Payable, Current |
|---|---|
| 2024-09-30 | $3.32M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.70M S-1/A · filed 2026-08-06 |
| 2024-03-31 | $7.99M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $10.20M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $9.34M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $9.11M 10-K · filed 2024-09-30 |
| 2023-03-31 | $6.39M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |